Crossmark

Safety evaluation of remdesivir administration in patients with severe renal impairment and coronavirus disease: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12879-025-11153-5

Published Online: 2025-06-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Umemura, Takumi

Kato, Hideo

Mutoh, Yoshikazu

Hagihara, Mao

Ikeda, Yoshiaki

Mikamo, Hiroshige
License Information

Text and Data Mining valid from 2025-06-02

Version of Record valid from 2025-06-02
More Information

Article History

Received: 17 April 2025

Accepted: 21 May 2025

First Online: 2 June 2025

Declarations

:

: Not applicable.

: Not applicable.

: HM received lecture fee from Gilead Sciences, Inc. All other authors report no potential conflicts.

Document is current

Any future updates will be listed below